UroGen Pharma Ltd. (URGN) Financial Statements (2024 and earlier)

Company Profile

Business Address 9 HA'TA'ASIYA ST
RA'ANANA, 4365007
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments99,96489,139102,018147,077101,318
Cash and cash equivalents55,40844,36052,86449,688101,318
Short-term investments44,55644,77949,15497,389 
Other undisclosed cash, cash equivalents, and short-term investments     
Restricted cash and investments8131,2261,226523253
Receivables12,70411,7177,047  
Inventory, net of allowances, customer advances and progress billings4,3254,8321,964  
Inventory4,3254,8321,964  
Other undisclosed current assets11,1017,4763,3641,034672
Total current assets:128,907114,390115,619148,634102,243
Noncurrent Assets
Operating lease, right-of-use asset2,4521,1802,1583,735
Property, plant and equipment1,2971,9672,046977948
Long-term investments and receivables 6751,89348,555 
Long-term investments 6751,89348,555 
Restricted cash and investments22322322322351
Other noncurrent assets2,7401,31166264317
Total noncurrent assets:6,7125,3566,38653,7541,316
TOTAL ASSETS:135,619119,746122,005202,388103,559
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12,38312,10210,02311,1868,540
Accounts payable5,5275,7863,2714,6944,272
Accrued liabilities4917291,2156821,786
Other undisclosed accounts payable and accrued liabilities6,3655,5875,5375,8102,482
Debt    1,585 
Other liabilities3,2763,3301,8591,585 
Other undisclosed current liabilities8,2576,9489,5545,1264,925
Total current liabilities:23,91622,38021,43619,48213,465
Noncurrent Liabilities
Long-term debt and lease obligation97,5373981,4972,604 
Long-term debt, excluding current maturities97,537    
Liabilities, other than long-term debt4,6042,8422,717  
Liability for uncertainty in income taxes3,0182,8422,717  
Operating lease, liability1,5863981,4972,604
Other undisclosed noncurrent liabilities98,92385,713   
Total noncurrent liabilities:201,06488,9534,2142,604 
Total liabilities:224,980111,33325,65022,08613,465
Equity
Equity, attributable to parent(89,361)8,41396,355180,30290,094
Common stock6361605744
Additional paid in capital487,787475,698452,525407,986212,921
Accumulated other comprehensive income (loss)(107)(25)271276 
Accumulated deficit(577,104)(467,321)(356,501)(228,017)(122,871)
Total equity:(89,361)8,41396,355180,30290,094
TOTAL LIABILITIES AND EQUITY:135,619119,746122,005202,388103,559

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues64,35748,04211,799191,128
Sublease income22422422419
Cost of revenue(7,654)(5,157)(1,009) (1,803)
Other undisclosed gross profit    (1) 
Gross profit:56,70342,88510,79018(675)
Operating expenses(135,744)(135,177)(137,529)(109,496)(76,505)
Operating loss:(79,041)(92,292)(126,739)(109,478)(77,180)
Nonoperating income (expense)723651,986(284) 
Investment income, nonoperating9383651,986  
Other nonoperating expense    (284) 
Interest and debt expense(8,438)    
Other undisclosed loss from continuing operations before equity method investments, income taxes   (357)  
Loss from continuing operations before equity method investments, income taxes:(87,407)(91,927)(125,110)(109,762)(77,180)
Other undisclosed income (loss) from continuing operations before income taxes(20,621)(17,444) 4,6161,648
Loss from continuing operations before income taxes:(108,028)(109,371)(125,110)(105,146)(75,532)
Income tax expense(1,755)(1,449)(3,374) (125)
Loss from continuing operations:(109,783)(110,820)(128,484)(105,146)(75,657)
Loss before gain (loss) on sale of properties:(110,820)(128,484)(105,146)(75,657)
Net loss available to common stockholders, diluted:(109,783)(110,820)(128,484)(105,146)(75,657)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net loss:(109,783)(110,820)(128,484)(105,146)(75,657)
Other comprehensive income (loss)   (5)276 
Comprehensive loss:(109,783)(110,820)(128,489)(104,870)(75,657)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(82)(296)   
Comprehensive loss, net of tax, attributable to parent:(109,865)(111,116)(128,489)(104,870)(75,657)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: